Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,155,180
-$594,525 QoQ
Shares Held
8,486
-24.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.89%
of 13F equity value
Holder Rank
#2,286
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Wealth Management LLC holds $7,869,904 across 14 Drug Manufacturers - General names. JNJ ranks #2 (27.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,276 | $2,334,208 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
8,486 | $2,155,180 | |
| 3 | NVS |
Novartis AG
|
6,045 | $947,369 | |
| 4 | AMGN |
Amgen Inc
|
1,542 | $558,386 | |
| 5 | LLY |
ELI LILLY & Co
|
370 | $443,788 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,329 | $307,055 | |
| 7 | PFE |
Pfizer Inc
|
12,072 | $290,687 | |
| 8 | NVO |
Novo Nordisk A S
|
4,946 | $237,111 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,155,180 | 8,486 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,749,705 | 11,249 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,353,435 | 11,372 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,137,521 | 11,528 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,760,291 | 11,524 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,953,761 | 11,781 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $1,728,209 | 11,950 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $2,001,603 | 12,351 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,058,517 | 14,084 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,309,732 | 14,601 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,028,372 | 12,941 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,289,836 | 14,702 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,666,858 | 16,112 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,534,870 | 16,354 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,887,697 | 16,347 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,685,638 | 16,440 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,917,021 | 16,433 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,920,041 | 16,476 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,817,522 | 16,470 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,661,197 | 16,478 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,787,400 | 16,920 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $2,779,651 | 16,913 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,711,500 | 17,229 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,516,072 | 16,900 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,632,593 | 18,720 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,250,453 | 17,162 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||